How the brain protein VGLUT may explain sex differences in dopamine neuron loss
Novel roles of VGLUT in sex differences in dopamine neuron vulnerability to environmental toxicant-induced neurodegeneration
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11254918
This project looks at whether a brain protein called VGLUT helps protect dopamine neurons differently in men and women, which could help explain differences in Parkinson’s disease timing and risk.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11254918 on ClinicalTrials.gov |
What this research studies
Researchers are studying a brain protein called VGLUT using fruit fly and rodent models plus human postmortem brain tissue to see how it affects dopamine neuron survival after exposure to environmental toxins. They will compare males and females, remove or reduce VGLUT in dopamine neurons in animals, and measure whether those neurons become more vulnerable to toxins and Parkinson’s-related proteins. The team will also examine human brain samples to see if the same VGLUT patterns seen in animals are present in people with Parkinson’s. The goal is to connect findings across species to better understand why women often show greater resilience to dopamine neuron loss.
Who could benefit from this research
Good fit: People living with Parkinson’s disease or adults with a history of pesticide or environmental toxin exposure would be most relevant to this line of research.
Not a fit: Patients with neurological conditions unrelated to dopamine neuron loss, or those seeking immediate clinical treatment, are unlikely to benefit directly from this basic science work.
Why it matters
Potential benefit: If successful, this work could point to new ways to boost VGLUT-related protection and slow or prevent dopamine neuron loss in Parkinson’s disease.
How similar studies have performed: Prior experiments in flies, rodents, and analyses of human brain tissue have already linked VGLUT to dopamine neuron survival, but translating that knowledge into therapies is still new.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FREYBERG, ZACHARY — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: FREYBERG, ZACHARY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.